Menu Search
Equities

Bio-Thera Solutions Ltd

688177:SHH

Bio-Thera Solutions Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)23.75
  • Today's Change-0.45 / -1.86%
  • Shares traded2.79m
  • 1 Year change-35.27%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Bio-Thera Solutions Ltd grew revenues 54.86% from 455.13m to 704.79m while net income improved from a loss of 480.40m to a smaller loss of 394.53m.
Gross margin69.81%
Net profit margin-45.77%
Operating margin-45.60%
Return on assets-16.17%
Return on equity-36.45%
Return on investment-26.76%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Bio-Thera Solutions Ltd fell by 27.58m. Cash Flow from Financing totalled 395.16m or 56.07% of revenues. In addition the company used 460.87m for operations while cash from investing totalled 37.57m.
Cash flow per share--
Price/Cash flow per share--
Book value per share2.05
Tangible book value per share1.50
More ▼

Balance sheet in CNYView more

Bio-Thera Solutions Ltd has a Debt to Total Capital ratio of 45.31%, a higher figure than the previous year's 25.60%.
Current ratio0.9506
Quick ratio0.716
Total debt/total equity0.8285
Total debt/total capital0.4531
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.